Datamonitor Healthcare Pharma intelligence informa Datamonitor Healthcare Content Calendar

Transcription

1 Datamonitor Healthcare 2017 Datamonitor Healthcare Content Calendar

2 2017 Content Calendar Published February 2017 Datamonitor Healthcare provides up-to-date insights and analysis that you can trust. Disease Reports Epidemiology and patient-based market forecasts, treatment algorithms, and marketed and pipeline drug analyses. Market assumptions are supported by in-depth and current primary research data, with sample sizes of over 200 specialists per indication. Drug Overviews Comprehensive overviews of marketed products and pipeline candidates across a full range of disease indications. Crohn s Disease Systemic Lupus Erythematosus Influenza Vaccines Breast cancer: HR+/HER2- Breast cancer: Triple-negative Glioblastoma Chronic Lymphocytic Leukemia Non-Small Cell Lung Cancer Diabetes Type 2 Acute Decompensated Heart Failure Osteoporosis Diabetic Nephropathy Non-Alcoholic Steatohepatitis (NASH) Parkinson s Disease Social Media in Pharma Mid Pharma Licensing and M&A Trends, Big Pharma Licensing Trends, Biosimilars Market Access in the US Biosimilars Access in the EU Integrated delivery networks in the US Immuno-oncology deal trends, Value-based reimbursement in the US Johnson & Johnson Novartis Bristol-Myers Squibb AbbVie Pfizer Eli Lilly Roche Amgen Novo Nordisk Merck & Co Q1 January March Datamonitor Healthcare Profiles Detailed analysis of the pipelines, performances, & future prospects for top pharma and emerging pharma and biotech companies. Trends & Market Access Reports: Market access, hot topics, and key trends shaping the industry that impact pricing and reimbursement, competitive dynamics, growth markets, and value chain issues.

3 Datamonitor Healthcare AstraZeneca Gilead GlaxoSmithKline Sanofi Bayer Teva Biogen Celgene Allergan Lundbeck Actelion Shire UCB Merck KGaA Boehringer Ingelheim Q2 April June Atopic dermatitis Ulcerative colitis Pneumococcal vaccines Chronic Obstructive Pulmonary Disease (COPD) Idiopathic Pulmonary Fibrosis Acute Myeloid Leukemia Hepatocellular Carcinoma Bladder Cancer Ovarian Cancer Lymphoma Pricing and Reimbursement Pulmonary Hypertension Dyslipidemia Diabetes Type 1 Venous Thromboembolism (VTE) Stroke Prevention in Atrial Fibrillation (SPAF) Bipolar Disorder Epilepsy New Data Strategies to Improve R&D Efficiency Early Market Access Pathways Big Pharma Diversification Strategies Trends in Generics in the US, Japan and five major EU Markets Biosimilars in Emerging Markets Payer Pharma Partnerships Use of Real-World Evidence Biosimilars Trial Strategies Lifecycle Management Strategies

4 Datamonitor Healthcare Daiichi Sankyo Dainippon Sumitomo Astellas Takeda Otsuka Eisai Mitsubishi Tanabe Shionogi Q3 July September HIV Dengue vaccines Meningococcal vaccines Asthma Cystic fibrosis Colorectal cancer Head and neck cancer Multiple Myeloma Chronic myeloid leukemia Leukemia Pricing and Reimbursement Age-related macular degeneration Pricing & Reimbursement Depression Obesity Chronic heart failure (CHF) Diabetic Nephropathy Stroke Orphan drug Pricing and Reimbursement The Future of Healthcare Reform and Drug Pricing in the US The Evolving Landscape in Pricing and Reimbursement Trends in Regenerative Medicine Pharma Product Portfolio Analysis Biosimilars Product Class Analysis Axial Spondyloarthritis Rheumatoid Arthritis Q4 October December

5 Datamonitor Healthcare Psoriasis Retina Disorders Inflammatory Bowel Disease Pricing and Reimbursement Hepatitis B Hepatitis C Syncytial virus (RSV) vaccines Chronic Obstructive Pulmonary Disease (COPD) Gastric Cancer Melanoma Prostate Cancer Renal Cell Cancer Alzheimer s Disease Multiple Sclerosis Schizophrenia Hemophilia Acute Coronary Syndrome Biosimilars Physician and KOL Insights Biosimilars ROI Analysis

6 The best coverage. The best forecasts. The best analysts. The best support. The Best of Health. We ve just made strategic investments in Datamonitor Healthcare to give you the best of health. Introducing The New Datamonitor Healthcare. We ve quadrupled our business intelligence which covers more than 90% of prescription medicines in the major markets. Our forecasts are tailored to your needs as events occur and are powered by a new forecasting tool built in collaboration with a leading analytics technology provider. We ve increased our global analyst resources by 300%, and Live Support replies to your queries in real time, not hours, for the fastest support in the market. Discover the best of health. Visit to tour the new Datamonitor Healthcare with one of our representatives. Request a live demo and see how The Best of Health supports smarter, faster decision-making.